American Health Research   Report issue

For profit Phase 2 Phase 4
Founded: Charlotte NC United States (2001)

Organization Overview

First Clinical Trial
2015
NCT02477709
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

American Health Research

Active Ingredients

Drugs in Phase 4 Trials (1)

guaifenesin (1 trial)

Drugs in Phase 2 Trials (1)

gefapixant (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Fibrosis (Phase 2)

Idiopathic Pulmonary Fibrosis (Phase 2)

Pulmonary Fibrosis (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 2